Product Approval Information - New Drug Application
Product name: Indium In-111 Chloride Solution
Manufacturer: Mallinckrodt, Inc, St. Louis, MO
Indication for Use: Use in radiolabeling Ibritumomab Tiuxetan (Zevalin) and remove use in radiolabeling Imciromab Pentetate (Myoscint)
Approval Date: 2/19/2002
Type of submission: New Drug Application Supplement
Approval Letter
(Text),
(PDF)
Label -
(PDF)
Last Updated: 3/22/2002
Back
to Top
Back to Index
Updated: September 26, 2003 |